59803-35-9

Basic information

• Product Name: DIETHYL 2-(2-NITROBENZYL)MALONATE
• Synonyms: DIETHYL 2-(2-NITROBENZYL)MALONATE;Diethyl (2-nitrobenzyl)propane-1,3-dioate;Diethyl 2-(2-nitrobenzyl)propane-1,3-dioate;diethyl 2-[(2-nitrophenyl)methyl]propanedioate
• CAS NO: 59803-35-9
• Molecular Formula: C₁₄H₁₇NO₆
• Molecular Weight: 295.29
• Mol File: 59803-35-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 386.9°Cat760mmHg
• Flash Point: 150.4°C
• Appearance: /
• Density: 1.227g/cm³
• Vapor Pressure: 3.43E-06mmHg at 25°C
• Refractive Index: 1.524
• Storage Temp.: 2-8°C
• CAS DataBase Reference: DIETHYL 2-(2-NITROBENZYL)MALONATE(CAS DataBase Reference)
• NIST Chemistry Reference: DIETHYL 2-(2-NITROBENZYL)MALONATE(59803-35-9)
• EPA Substance Registry System: DIETHYL 2-(2-NITROBENZYL)MALONATE(59803-35-9)

Safety Data

• Hazardous Substances Data: 59803-35-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C14H17NO6/c1-3-20-13(16)11(14(17)21-4-2)9-10-7-5-6-8-12(10)15(18)19/h5-8,11H,3-4,9H2,1-2H3

Upstream product

• 17455-13-9 18-crown-6 ether 
• 612-23-7 2-nitrobenzyl chloride 
• 105-53-3 diethyl malonate 
• 3958-60-9 2-nitrophenylmethyl bromide 
• 17422-56-9 diethyl 2-(2-nitrobenzylidene)malonate 
• 64-17-5 ethanol 
• 683215-25-0 (2-nitro-benzyl)-malonic acid 

Downstream Products

• 2001-32-3 3-(2-nitrophenyl)propionic acid 
• 88-72-2 1-methyl-2-nitrobenzene 
• 18910-10-6 α-bromo-β-(2-nitrophenyl)propionic acid 
• 104145-71-3 2-hydroxy-3-(2-nitro-phenyl)-propionic acid 
• 861356-74-3 bromo-(2-nitro-benzyl)-malonic acid 
• 612-41-9 2-nitrocinnamic acid 
• 24623-25-4 4-nitro-2,3-dihydro-1H-inden-1-one 
• 85397-21-3 3-(2-nitro-phenyl)-propionyl chloride 
• 1211547-70-4 C₂₄H₃₇NO₇Si 
• 683215-25-0 (2-nitro-benzyl)-malonic acid 

Relevant articles and documents

NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF

The present invention provides a novel compound having an agonist action at AT2 receptor and expected as a pharmaceutical product, and also provides a method of treating or preventing various diseases. The novel sulfonyl malonamide derivative,

Modified pyrimidine glucocorticoid receptor modulators

The present invention provides a novel class of modified pyrimidine compounds and compositions and methods of using the compounds as glucocorticoid receptor modulators.

TETRAHYDRO-NAPHTHALENE AND UREA DERIVATIVES

This invention relates to tetrahydro-naphthalene and urea derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations. The tetrahydro-naphthalene and urea derivatives of the present invention have vanilloid receptor (VR1) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor oeractivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD). BHC 03 2 001-Foreign-Countries - 66 - BHC 03 2 001-Foreign-Countries - 65 -